We still do not know enough about the aetiology and pathogenesis of schizophrenia, nor are the therapeutic methods generated by our definition of it satisfactory. Therefore, innovative approaches to treating schizophrenic patients, even if they only promise some partial progress, warrant consideration. The purpose of the pilot project 'Soteria Berne' is to assess the effectiveness of an open residential programme which has been providing mainly psychotherapy, sociotherapy, and milieu therapy instead of standard pharmacotherapy to about 60 acute schizophrenic patients for more than six years.
The project is based on three underlying concepts: firstly, a multiconditional understanding of ,schizophrenia, generated by the first author's investigations of the long-term course of illness and his concept of "affect logic", according to which affects/emotions organise and integrate cognitions with which they are comprehensively linked (Ciompi 1987 (Ciompi , 19880, 1991 . Secondly, on experiences reported by American authors in the 1970s in the first 'Soteria House' near San Francisco, and thirdly, on a number of other psychotherapeutic, sociotherapeutic, and pharmacological strategies which have been developed by other authors;
The three-phase multiconditional evolutionary model of schizophrenia which has been described elsewhere (Ciompi, 1983 (Ciompi, , 1987 (Ciompi, , 1988b is based on a modified version of the vulnerability _theory formulated by Zubin & Spring (1977 ), Nuechterlein & Dawson (1984 , and others. Schizophrenics are defined as highly sensitive individuals with impaired information-processing capacities reducing their ability~o cope with critical life events such as leaving home, first sexual experiences, choosing a job or a spouse, pregnancy and childbirth, and major changes In residence or life circumstances: Under unfavourable conditions, escalating emotional tensions between patient and environment reach a critical point of instability, characterised by the appearance of acute psychotic symptoms. Psychotic decompensation can be defined as a severe developmental crisis, bearing the risk of total failure, but concurrently as a chance to grow and change.
This model has the following therapeutic implications: patients trapped in such a crisis need continual psychotherapeutic help and emotional support. Their difficulties in information-processing should be alleviated in a calm, relaxing, and stimulus-reducing therapeutic setting, where a stable team ensures continuity, and provides patients and their family with clear and reliable information about the illness. However, repeated change in therapeutic setting and therapist, emotional or intellectual overstirmilation (Wing & Brown, 1970) , 'high expressed emotion' in the family (see Leff et ai, 1982) , and confusing and contradictory information about the therapeutic situation, the purpose of therapy and the methods employed, should all be avoided as much a<; possible. It follows that the confusing and violent atmosphere endemic in the large admission wards of psychiatric hospitals, where a majority of acute psychotic patients are still being treated, is particularly unsatisfactory. Small treatment facilities offering a sheltered and supportive environment may be more effective in treating schizophrenic patients than such . traditional settings.
. The San Francisco 'Soteria House' project conceived by. Mosher & Menn in the 1970s and investigated by a US National Institute of Mental Health study, is stated to have produced positive results (Mosher et ai, 1975 (Mosher et ai, , 1990 Mosher & Menn, 1978; Matthews et at, 1979; Wilson, 1982) with the need for neuroleptic treatment dramatically reduced. The outcome oftreafment was predominantly positive for about 200 acute schizophrenic ¢ttients maintained on low-dosage or no neuroleptic medication. After six weeks, no significant differences in the level of psychopathology could be found between 28 inde/{ patients treated without drugs and 11 control patients receiving a daily average dosage of 7oo,mg chlorpromazine equivalents (Mosher et 01, 1990>',' whileaJter two years, no significant differences were reported in relapse rates or psychopathology. However, ttie index patients had a better level of social adjustment, experienced their illness to be less distressing, were using significantly lower total doses of neuroleplics, and incurred lower treatment costs. These-findings, ' CIOMPl ET AL which are interesting in connection with the problem of both short-and long-term side-effects of neuroleptics, have to date not been subject to systematic analysis or Teplication.
The pr'oject discussed here borrowed certain therapeutic and administrative tools, such as the 'soft room' and nurse's timetables (see below), from the initial Soteria experiment. The same name (a rough translation from Greek meaning safety, security, salvation) was used, despite the fact'that 'Soteria Berne' differs from Mosher's approach in various ways: it is based on a medical model integrating psychosocial and biological factors, the programme is under medical supervision, and it incorporates, in addition, the following therapeutic strategies: (a) the 'educational approach' and family treatment strategy (Leff et aI, 1982; Anderson, 1983; Hubschmid, 1985) intended to establish close collaboration between family, significant others, and carers; (b) long-term after-care and relapse prevention (Hogarty, 1984; Dauwalder, 1988) ; (c) inducing positive expectations (Ciompi el ai, 1979) by providing everyone involved in the therapy process with clear and up-dated information about the illness, its treatment, the longterm ris k of relapse, and ·the chance of recovery, according to follow-up studies which have demonstrated that long-term outcome is substantially more favourable and he'terogenous than hitherto believed (Ciompi & Muller, 1976; Bleuler, 1978; Huber et ai, 1979) ; (d) administration of low and targeted medication as viable alternatives to drug-free strategies (Carpenter el ill, 1977 (Carpenter el ill, , 1987 (Carpenter el ill, , 1990 Herz et ai, 1982; Kane el ai, 1983 Kane el ai, , 1987 Chiles et ai, 1989) (a) aged 17-35 (bl a recent onset of a schizophrenic or schizophrenifonn psychosis defined according to DSM-1I1-R criteria (American Psychiatric Association. 1987), not more than one year before admission (c) at least two of the following six symptoms within the previous four weeks: delusions, hallucinations, thought disorders, catatonia, schizophrenic disorders of affect, severely deviant social behaviour.
The exclusion criteria consisted of dependency on drugs or alcohol, and totally lacking compliance with (reatmeRl.
Referral to Soteria is usually made by the local emergency service, but patients are al~o sometimes referred by local psychiatric hospitals or private persons. Random admission is attempted by accepting patients who fulfil the abovementioned criteria whenever a bed is available, Some bias is however created by the fact that severely agitated peracute patients are quite often directly referred to nearby psychiatric hospitals without passing through the emergency service, and compulsory treatment is generally not possible in the open 'Soteria' setting. Furthermore, some patients with longer-lasting illness, chronic course, and severe negative symptoms have been admitted under ·different circumstances. Therefore, the index population may have contained patients who were somewhat easier to treat, but also with less favourable outcome prospects than a typical population of acute patients with a shorter duration of' illness and no severe negative symptoms,
The therapeutic team consists ofa part-time mediCal director, five psychiatric nurses, and four paraprofessionals selected according to their motivation, life experience, and ability to show empathy and interpersonal involvement with schizophrenic patients, Two staff members always work in overlapping 48-hour shifts followed by several days off. The team has weeklY half-day meetings to review cases. Once every l.
SOTERIA BERNE two weeks the team is supervised by an experienced psychotherapist.
Treatment is divided into four phases: each patient is assigned his own carer who stays constantly with him during the initial and most acute phase. He is cared for in the 'soft room', which is a large and pleasant one on the ground floor. There are only cushions and mattresses in this room so as to avoid any sort of danger or over-stimulation. The main purpose of this phase is to reduce anxiety and tension by providing the patient with constant human support and guidance by calming him down, or by implementing relaxation techniques such as massage, holding hands, short walks, or other physical activities. Next comes the activating phase, characterised by gradually getting back into touch with reality -first by negotiating simple household and gardening chores within the sheltered environment of the therapeutic setting, and later doing the shopping and going for walks near the house. The third phase focuses on gradual social and vocational rehabilitation by expanding the patient's s·ocial network and helping him to make the transition from hospital to independent living by providing part-time employment or placement in a sheltered workshop, etc. The fourth phase, which lasts for at least two years after discharge, focuses 011 prevention of relapse and psychosocial stabilisation. It is carried out by a mobile community-based social-psychiatric team or by private psychiatrists.
. Psychosocial therapy focuses on the patient's basic life problems and on treating the experience of psychosis as an· integral part of the patient's life. At·the beginning, each patient is o~fered ongoing support and guidance as r~uired, by two carers who are specifically assigned to do this. Eventually, he might be offered individual or family therapy, according to the circumstances. Relati ves and significal'lt others are systematically involved in the therapy process: they are informed about the illness whenever an appropriate situation arises and information is also disseminlited in problem-centred workshops which~ake place evCTY six weeks. Psychoanalytical and systemic family therapeutic approaches continually figure in psychosocial interventions, for example, in efforts to strengthen personal identity, to clarifyintrafamilial responsibilities to reinforce interpersonal and generational boundaries, 0;to negotiate concr~te priorities and objectives, for example housing or vocational arrangements.
Results
The following can be reported at present: clinical observations, some data concerning the irnrriediate outcome on discharge of~patients treated at Soteria between I May 1984 and 30 April 1990, and outcome comparisons over a two-year period between the first 14 index and control p~tients. More~etailed information, including methods, is given elsewhere In a German-language publication (Ciompi et ai, 1991 The great majority of patients stayed at Soteria for an average of 1-4 months (Fig. I) . . On the whole, the first three phases of the treatment approach may be considered quite successful. There were only three incidents within six years when a patient incurred serious harm to himself or others. Several patients who remained drug-free for a period ranging fr010 several weeks 19 2. rather good (category~or 2 in two of three ratings) 12 3. rather poor (category 3 or 4 in two of three ratingsl 9 4. poor lcategory 3 or 4 in three ratings) 9 5. uncertain (category 'uncertain' in two or three ratings) 2 to a number of months had less severe psychotic symptoms, although the time spans for this effect to occur were usually longer than those reported by Mosher et af (1975; Mosher & Menn, 1978) . This was one of the reasons for the increased implementation of targeted or low-dose neuroleptic medication strategies as time passed. However, relapse prevention often proved to be more difficult than expected during the aftercare phase of the programme. This was mainly because many patients and their relatives refused to acknowledge either the patient's speqial vulnerability or the necessity of guidance and care, even though they had been informed about the nature of the illness. Medication was, therefore, administered on an as-needed basis during this phase of treatment.
Five of the 56 patients were discharged within 10 days and are therefore not included in the following statistical analysis. Twenty of the 5J remaining patients received no neuroleptic treatment at Soteria, and 31 received neuroleptics for approximately 2/3 of their stay in average daily doses of J72.5 mg chlorpromazine equivalents (calculated according to Haase, 1982) or 94.2 mg per day of total treatment. This corresponds to approximately 1/3 of the usual European, and about I /5-II 10 of the usual American doses. Psychopathology upon release, housing situation and occupational situation after release, and a global outcome rating were as shown in Table I .
In 31 (61070) out of 51 cases, the immediate global outcome was classified as 'good', or 'fairly good', and in 18 (35.30/0) as 'rather poor' or 'poor', suggesting that the , programme was successful in a major subgroup, but unsuccessful in a minor subgroup of psychotic patients. Immediate outcome is shown in Fig. 2 . A number of significant differences were found between 'responders' and 'non-responders' (Table 2) : for certain aspects of outcome, there were better results in women than in'men, in patients with a shorter duration of illness, and in schizophreniform psychoses v. schizophrenia defined and a number of non-significant trends point in the same direction.
Comparisons were made of the two-year-outcomes between the first J4 index cases and an eq!lal number of matched control cases from four different hlstitutions (the milieu therapy-orientated private psychiatric hospital 'Schliissli' in Oetwil, Switzerland; a modern psychiatric ward at Lucerne General Hospital in Switzerland; the t.raqitionalBtate Psychiatric Hospital in St. Urban/Lucerne in Switzerland; and the State Psychiatric Hospital "PhilipsHopsital" near Riedstadt in Germany). The Ward Atmosphere Scale (Moos, 1974; Henrich el af, 1979) signi ficantly differentiated Sotaria from the four control institutions with respet'l to therapeutic atmosphere (Fig. 3) .
Matched-pair comparisOns were made by matching index and control patients with respect to their age, sex, and the two most relevant predictors, premorbid social adjustment and prevailing positive or negative symptoms. The results of this comparison are summarised in Fig. 4 : no significanl differences were found for 7 out of a total of 9 outcome and progression variables. The variables included (a) psychopathology measured by BPRS (Overall & Go'rham, 1962) costs. In both groups, 10 out of 14 cases (7IA070) had relapses over 2 years; 9 index patients and 7 control patients had to be readmitted as day-. or in-patients. Significant differences were found only for (g) mean daily dose 14 13
A'" 12 11 10
Organisation and order 9 8 (99 mg v. 103 mg average daily dose, and 68.968 mg v. 67.713 mg average total.dose) (Fig. 4) . During the total· twoyear period of observation, the difference amounts to about (:2 (83.662mg v. 172.911 mg average-total doses).
Correlations which were found between possible predictors and housing situation, job situation, psychopathology, and combined global outcome are shown in Table 3. . . BeUer outcomes (partly for both index~patients and control pati~nts. and partly only for thl; one or the other) were statistically correl'ated with female sex, above-average age, higher professional training, better premorbid social functioning, higher premorbid autonomy, shorter duration of illness and of previous treatment, and absence of previous Seven 01.lt of 14 index patients and all 14 control patients received neuroleptic treatment during the initial in~patient treatment phase. During aftercare, 8 out of J4 index cases and J2 out of 14 control cases were treated with neuroleptics. Four index patients did not· receive neuroleptics either during the !nitiOOJieatment phase or duripg after-care; all four cas-es were diagnosed as having . schizophreniform psychoses and had a good outcome. . Index patients received significantly smaller daily and cumulative neuroleptic doses than control patients: during the inhe differences amounted to more than. 1 :30' . average daily dose) and more than J : 7 ( ,(.~~g;,t'J~ §..t 98 mg average tctal dose), whereas
. there re no s'igruficant differences .during after-carẽ .. Table 3 Correlations between possible predictors and two yLar outcome in terms of immediate outcome, has been successful in about two-thirds of cases. It is particularly interesting that for certain patients, a remission of symptoms can occur without neuroleptic medication, and that drug-free or low-dose medication strategies have been correlated with better outcomes in several respects. The results of the two-year prospective study on the first 14 index cases and matched controls are also surprising insofar as they show no significant differences between standard treatment and the Soteria approach with respect to psychopathology, housing arrangements, job situation, combined global outcome, social autonomy, and relapse rate, in spite of much smaIier daily and total doses of neuroleptic medication. This confirms findings by Mosher et af (1975 , 1990 and by Mosher & Menn (1978) . On the other hand, treatment costs were significantly higher for the Soteria patients.
Thus, it seems that in a special therapeutic setting which offers adequate and continual emotional support, comparable outcome in the long term can Discussion More than six years of experience with a significantly sized group of schizophrenic patients show that the innovative therapeutic approach implemented in' Soteria Berne is applicable to clinical practice, and . psychotic episodes. In terms of medication, outcomes were statistically better for patients who did not r~ceive neuroleptics during after-care, or received them for a shorter than average duration and at higher than average doses during the treatment phase, but at lower than average doses during after-care. Furthermore, index-patients who received lower than average total doses during the treatment phase' had statistically beller outcomes. ' On the whole, practically all correlations concerning . general and social predictors w~re in the direction expected according to the literature (e.g. Hubschmid & Ciompi. 1990). However, they contradicted expect.ation concerning the absence of the predictive power of diagnostic subgroups and the generally more favourable aspects of outcome for patients who were maintained on targeted; low-dose or noneuroleptic ·medication strategies. be achieved despite a substantial reduction in the cumulative use of medication, while some drug-free patients are found to have positive outcomes after two years of study. This finding is particularly interesting with :regard to ta-rdive dykinesia which has some relationship to the cumulative neuroleptics administered (Carpenter, 1990) . The findings reported are compatible with the hypothesis of central organising and integrating functions of the affects (Ciampi, 1991) , and partially validate the underlying psychosociobiological understanding of schizophrenia derived from the concept of 'affect logic' (Ciompi, 1988a,b) . A unilaterally biological concept of schizophrenia would hardly suffice to explain them.
All these findings, however, should be interpreted with great caution. Statistical correlations in favour of patients who received no or low-dose neuroleptic medication do not provide evidence for the hypothesis that drug-free treatment is superior to conventional neuroleptic medication strategies, because only more difficult cases were given neur'oleptics or higher doses of them. Furthermore, the number of matched-pair comparisons over two years was small, and the influence of important mediating variables such as duration and dosage of medication, environmental influences, spontaneous remission rates, etc. has not yet been sufficiently investigated.
The practically identical relapse rates for both medication strategies can be explained by the fact that both groups were maintained on roughly identical total dose levels during after-care. Therefore, slightly higher rates of readmission among index patients' cannot be related to differences in drug prophylaxis. Soteria patients might, however, be less' reluctant to return to the treatment facility than patients treated in traditional hospitals.
Higher treatment costs in Soteria probably have less to do with the low-Or no-medication strategies adopted than with the prolongation of treatment, caused by the inclusion of phase 3 (rehabilitation) in the treatment process. Furthermore, higher initial costs are to be expected in a pilqt project. It is certainly possible to cut .costs by referring patients to less expensive rehabilitation facilities and this has already been initiated. However,.in the face of the ,immeasurable human and economic costs of the unsolved problem of schizophrenia, financial reasons alone should certainly not hinder the search for improved therapeutic methods.
Although it appears that under emotionally favourable cOl)ditions, a low-or no-medication strategy, combined with psychotherapy and sociotherapy is a feasible and effective alternative to conventional treatment for schizophrenic patients, the question of how to differentiate 'responders' from 'non-responders ' has not yet been clarified. Some of the findings reported (better results for schizophreniform psychoses, women, and premorbidly more autonomous first-episode cases with short duration of illness and no previous treatment elsewhere) support the assumption that a drug-free treatment condition, focusing on $lieu therapy and psychotherapy, may be more suitable for new cases suffering from less severe disorders. Moreover, the fact that the last three predictors of favourable outcome are valid only for index patients and not for control patients (see Table 2 ) suggests that this therapeutic approach might be suitable mainly for patients who did not have the chance to learn the typical roles and behavioural patterns characteristic of psychiatric in-patients. Finally, on the subjective level of experience, most patients and relatives found treatrn,ent at Soteria to be less upsetting and less stigmatisin~than traditional methods. Soteria p...tients appeared' to be more able to integrate their psychosis into their lives and personal development than patients being treated in customary psychiatric facilities.
On the whole, the findings reported provide some hope of improving methods of treating at least one major subgroup of psychotic patients by using the Soteria approach.
